SCIENTIA ADVISORS: NEWS

Harry Glorikian, Managing Partner and Management Consultant of Scientia Advisors, will be speaking at the 2nd Annual Diagnostics Asia on Understanding the State of the Diagnostics Industry and Identifying Commercial Opportunities in Point-of-Care Testing. The topics discussed will be:

COURSE DESCRIPTION
The diagnostics market is a modest growth market with several segments that show different growth prospects. The overall industry outlook is very positive - driven by favorable demographics, health care cost pressures, industry consolidation, and new high value products. Point of care (POC) diagnostics is an important segment of IVD that is gaining traction. Need for decentralization, reduced healthcare expenditures to enable better health management are key drivers of POC diagnostics. This course outlines the IVD industry dynamics, identifies opportunities in POC, emerging POC trends & technologies, and key market forces that influence the point of care market.

COURSE AGENDA
IVD overview

• IVD industry dynamics


• Key growth drivers


• Market forces such as convergence, emergence of rapid clinics that will change the delivery of IVD and patient care

Point of care (POC) market overview

• POC industry dynamics


• Key growth drivers, customer segments, regulatory & reimbursement overview


• POC technology review and history overview


• Conclusion on POC opportunities

Harry Glorikian's experience allows him to cover a broad range of areas within life sciences. His direct experience in sales, marketing, business development, and intellectual property combined with his technical and market knowledge provides unique and insightful perspectives. Harry has 15 years of experience in the life sciences developing and executing key strategic acquisitions and licensing arrangements targeting revenue growth channels. Harry currently leads Scientia, including the management of consulting teams, new business development, and intellectual capital development. His client engagements have involved comprehensive go-to-market plans in the areas of diagnostics, genomic, proteomics, cell biology, cellular therapy and consumables & services groups. His clients include both emerging innovators and global market leaders.

For more information please visit: http://www.ibc-asia.com